Chemotherapeutic agents represent a cornerstone in cancer treatment, comprising a diverse array of drugs designed to combat the proliferation of cancer cells. These agents operate through various mechanisms, including inhibiting cell division, disrupting DNA replication, and inducing apoptosis (cell death) in malignant cells. Over the years, research has led to the development of increasingly targeted and personalized chemotherapies, aiming to minimize adverse effects on healthy tissues while maximizing efficacy against tumors. From traditional cytotoxic drugs to modern molecularly targeted therapies and immunotherapies, the landscape of chemotherapeutic options continues to evolve. Ongoing cancer research focuses on optimizing drug delivery methods, overcoming drug resistance, and exploring synergistic combinations to enhance treatment outcomes and improve the quality of life for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States